{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:35:42Z","timestamp":1790962542305,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["1004932"],"award-info":[{"award-number":["1004932"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.neulet.2024.137914","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:33:35Z","timestamp":1721356415000},"page":"137914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["CSF dynamics of orexin and \u03b2-amyloid42 levels in narcolepsy and Alzheimer\u2019s disease patients: a controlled study"],"prefix":"10.1016","volume":"837","author":[{"given":"Susana","family":"Lozano-Tovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Nuccetelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sancesario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Biagio Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2024.137914_b0005","series-title":"International Classification of Sleep Disorders-Third Edition","author":"American Academy of Sleep Medicine","year":"2014"},{"key":"10.1016\/j.neulet.2024.137914_b0010","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, APA. (2013). Diagnostic and Statistical Manual of Mental Disorders, DSM-5 (APA). https:\/\/www.psychiatry.org\/.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.neulet.2024.137914_b0015","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1","volume":"zsz215","author":"Baiardi","year":"2019","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.neulet.2024.137914_b0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy\u2014Clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.neulet.2024.137914_b0025","doi-asserted-by":"crossref","first-page":"e33525","DOI":"10.1371\/journal.pone.0033525","article-title":"Executive control of attention in narcolepsy","volume":"7","author":"Bayard","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.neulet.2024.137914_b0030","doi-asserted-by":"crossref","unstructured":"Benca, R. M., & Teodorescu, M. (2019). Sleep physiology and disorders in aging and dementia. En Handbook of Clinical Neurology (Vol. 167, pp. 477-493). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00026-1.","DOI":"10.1016\/B978-0-12-804766-8.00026-1"},{"issue":"4","key":"10.1016\/j.neulet.2024.137914_b0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/ejn.15077","article-title":"Dysregulation of the orexin\/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders","volume":"53","author":"Berteotti","year":"2021","journal-title":"Eur J Neurosci."},{"key":"10.1016\/j.neulet.2024.137914_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-009-1596-2","article-title":"Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867 disrupts attentional performance in rats","volume":"206","author":"Boschen","year":"2009","journal-title":"Psychopharmacology (berl)."},{"key":"10.1016\/j.neulet.2024.137914_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.08.024","article-title":"Intranasal administration of orexin peptides: mechanisms and therapeutic potential for age-related cognitive dysfunction","volume":"1731","author":"Calva","year":"2020","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neulet.2024.137914_b0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2024.137914_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00119","article-title":"Hypocretin and brain \u00ce2-amyloid peptide interactions in cognitive disorders and narcolepsy","volume":"6","author":"Dauvilliers","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.neulet.2024.137914_b0060","doi-asserted-by":"crossref","unstructured":"Davies J, Chen J, Pink R, Carter D, Saunders N, Sotiriadis G, Bai B, Pan Y, Howlett D, Payne A, Randeva H, Karteris E (2015). Orexin receptors exert a neuroprotective effect in Alzheimer\u2019s disease (AD) via heterodimerization with GPR103. Sci Rep. Jul 30:5:12584.","DOI":"10.1038\/srep12584"},{"issue":"6","key":"10.1016\/j.neulet.2024.137914_b0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","article-title":"The cerebrospinal fluid \u00abalzheimer profile\u00bb: Easily said, but what does it mean?","volume":"10","author":"Duits","year":"2014","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/j.neulet.2024.137914_b0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2009.08.046","article-title":"Orexin\/hypocretin modulation of the basal forebrain cholinergic system: role in attention","volume":"1314","author":"Fadel","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2024.137914_b0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta; 42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1016\/j.neulet.2024.137914_b0080","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer\u2019s disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"September","key":"10.1016\/j.neulet.2024.137914_b0085","article-title":"Alzheimer\u2019s disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes","volume":"64","author":"Havekes","year":"2019","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.neulet.2024.137914_b0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.08.019","article-title":"CSF pro-orexin and amyloid-\u03b238 expression in Alzheimer\u2019s disease and frontotemporal dementia","volume":"72","author":"Heywood","year":"2018","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neulet.2024.137914_b0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbscr.2016.08.002","article-title":"Sleep in Alzheimer\u2019s disease-beyond amyloid","volume":"2","author":"Holth","year":"2017","journal-title":"Neurobiology of Sleep and Circadian Rhythms"},{"issue":"7S_Part_3","key":"10.1016\/j.neulet.2024.137914_b0100","doi-asserted-by":"crossref","first-page":"P165","DOI":"10.1016\/j.jalz.2015.07.113","article-title":"Effects of disrupted sleep on abeta and tau pathology and effects of abeta and tau pathology on sleep: A vicious cycle?","volume":"11","author":"Holtzman","year":"2015","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1016\/j.neulet.2024.137914_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2011.235","article-title":"Effects of age and amyloid deposition on a\u03b2 dynamics in the human central nervous system","volume":"69","author":"Huang","year":"2012","journal-title":"Archives of Neurology"},{"issue":"5955","key":"10.1016\/j.neulet.2024.137914_b0110","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neulet.2024.137914_b0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3233\/JAD-180769","article-title":"Cerebrospinal fluid orexin levels and nocturnal sleep disruption in alzheimer's disease patients showing neuropsychiatric symptoms","volume":"66","author":"Liguori","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.neulet.2024.137914_b0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.sleep.2019.01.003","article-title":"Obstructive sleep apnea may induce orexinergic system and cerebral \u03b2-amyloid metabolism dysregulation: Is it a further proof for Alzheimer\u2019s disease risk?","volume":"56","author":"Liguori","year":"2019","journal-title":"Sleep Medicine"},{"issue":"1","key":"10.1016\/j.neulet.2024.137914_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11325-015-1305-9","article-title":"Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time","volume":"20","author":"Liguori","year":"2016","journal-title":"Sleep and Breathing"},{"issue":"12","key":"10.1016\/j.neulet.2024.137914_b0130","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","article-title":"Orexinergic system dysregulation, sleep impairment, and cognitive decline in alzheimer disease","volume":"71","author":"Liguori","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.neulet.2024.137914_b0135","doi-asserted-by":"crossref","unstructured":"Liguori C, Placidi F, Izzi F, Spanetta M, Mercuri NB, Di Pucchio A. (2020) Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course. Alzheimers Res Ther. Jan 4;12(1):5.","DOI":"10.1186\/s13195-019-0571-3"},{"issue":"1","key":"10.1016\/j.neulet.2024.137914_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.26641","article-title":"Suvorexant acutely decreases tau phosphorylation and A\u03b2 in the human CNS","volume":"94","author":"Lucey","year":"2023","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2024.137914_b0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-\u03b2(1\u201342), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clinical Chemistry"},{"issue":"4","key":"10.1016\/j.neulet.2024.137914_b0150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbi.2003.11.002","article-title":"Exploring the cytokine and endocrine involvement in narcolepsy","volume":"18","author":"Okun","year":"2004","journal-title":"Brain, Behavior, and Immunity"},{"issue":"6","key":"10.1016\/j.neulet.2024.137914_b0155","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.5665\/sleep.5846","article-title":"Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects","volume":"39","author":"Osorio","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.neulet.2024.137914_b0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2014.10.041","article-title":"Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task","volume":"1594","author":"Piantadosi","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2024.137914_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113015","article-title":"Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses","volume":"399","author":"Prajapati","year":"2021","journal-title":"BEhav Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2024.137914_b0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nature Reviews Neuroscience"},{"issue":"7","key":"10.1016\/j.neulet.2024.137914_b0175","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.neurobiolaging.2010.12.008","article-title":"Coexistence of narcolepsy and Alzheimer\u2019s disease","volume":"33","author":"Scammell","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"10.1016\/j.neulet.2024.137914_b0180","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2174\/156720512804142840","article-title":"Association between Hypocretin-1 and Amyloid- 42 Cerebrospinal Fluid Levels in Alzheimer\u2019s Disease and Healthy Controls","volume":"9","author":"Slats","year":"2012","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neulet.2024.137914_b0185","doi-asserted-by":"crossref","unstructured":"Toor, B., Ray, L. B., Pozzobon, A., & Fogel, S. M. (2021). Sleep, Orexin and Cognition. En M. A. Steiner, M. Yanagisawa, & M. Clozel (Eds.), Frontiers of Neurology and Neuroscience (Vol. 45, pp. 38-51). S. Karger AG. https:\/\/doi.org\/10.1159\/000514960.","DOI":"10.1159\/000514960"},{"issue":"5","key":"10.1016\/j.neulet.2024.137914_b0190","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neulet.2024.137914_b0195","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nature Neuroscience"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T13:11:26Z","timestamp":1734613886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394024002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"alternative-id":["S0304394024002921"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137914","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF dynamics of orexin and \u03b2-amyloid42 levels in narcolepsy and Alzheimer\u2019s disease patients: a controlled study","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"137914"}}